Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort
研究概览
详细说明
Primary Objective:
The primary objective of this study is to characterize procedural anxiety trajectories in pediatric patients ages 2-12 undergoing radiation therapy. Anxiety will be measured using the Modified Yale Preoperative Anxiety Scale Short Form (mYPAS-SF) at standardized clinical milestones (simulation, first week of treatment, mid-treatment, and final treatment week).
Secondary Objectives:
Secondary objectives are to explore associations between observed anxiety levels and treatment-related contextual factors, including:
- Treatment fraction number
- Anesthesia use
- Child-life support
- Parent or caregiver presence
- Waiting times of 30 minutes or longer
- Time of day
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Susan L McGovern, MD, PHD
- 电话号码:(713) 563-2336
- 邮箱:slmcgove@mdanderson.org
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- 招聘中
- UT MD Anderson
-
接触:
- Susan L McGovern, MD, PHD
- 电话号码:713-563-2336
- 邮箱:slmcgove@mdanderson.org
-
首席研究员:
- Susan L McGovern, MD, PHD
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
To be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent from a parent or legal guardian.
- For children age 7 and older, provision of informed assent in addition to parental consent, consistent with institutional guidelines.
- Stated willingness of parent/guardian and child (as appropriate) to comply with study procedures (i.e., observation during scheduled radiation therapy appointments).
- Male or female, ages 2-12 years.
- Scheduled to undergo radiation therapy at MD Anderson Cancer Center.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
- Has already completed the simulation session for radiation therapy prior to enrollment.
- Declines parental consent or, when applicable, child assent.
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
安全性和不良事件 (AE)
大体时间:通过学习完成;平均1年。
|
不良事件发生率,根据美国国家癌症研究所不良事件通用术语标准 (NCI CTCAE) 版本 (v) 5.0 进行分级
|
通过学习完成;平均1年。
|
合作者和调查者
调查人员
- 首席研究员:Susan L McGovern, MD, PHD、UT MD Anderson
出版物和有用的链接
有用的网址
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.